ArticlePathogens (Basel, Switzerland)2026
Sensitivity and Specificity Assessment of Various African Swine Fever ELISA Kits for Accurate Detection of Seropositive Wild Boar.
Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and Evaluation of Three Indirect ELISA Methods Based on Novel Recombinant ASFV Antigens for Serological Detection of African Swine Fever.Pathogens (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The continuous and rapid spread of African swine fever (ASF) still poses a significant threat to Eurasian wild boar and domestic pigs, leading to substantial economic losses in all associated sectors annually. In Europe, including Germany, affected wild boar populations have become an important driver and host of ASF virus (ASFV), and monitoring and surveillance is key to tailor control measures that impede viral spread. While molecular methods are used to confirm the disease and to monitor viral evolution, serology gains importance in endemically affected regions as it provides insights into disease dynamics and possible attenuation of ASFV strains. Frontline serological diagnosis is done using ELISA assays, of which several are commercialized. However, accurate performance of ELISA assays is key for correct interpretation of wild boar samples. Due to the various stages of hemolysis and decay, field samples from wild boar can be challenging for ELISA assays. To assess which indirect or competitive ELISA kit performs best when dealing with such samples, we compared the sensitivity and specificity of four commercially available ELISA kits that are licensed in Germany, as well as three unlicensed but commercially available kits. For this comparison, we used all wild boar samples submitted to the National Reference Laboratory (NRL) for ASF in years 2021 and 2022, as well as samples from domestic pigs to have a control cohort where sample quality is optimal. We observed that wild boar samples, varying in stage of hemolysis and decay, were challenging for all kits included in this study. However, samples of domestic pigs were largely interpreted correctly by ELISA, using immunoperoxidase test as verification method. Additionally, the comparability of results obtained by regional laboratories was high. Our study provides data that highlights the importance of careful kit selection, assessment of sample quality, and data interpretation for effective ASFV surveillance and control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.